FDA Clearance of an Investigational New Drug (IND) Application for MesenCure™ Phase III Clinical Study in Respiratory Distress News March 4, 2025Bonus Biogroup Announces U.S. Food and Drug Administration (FDA) Clearance of an Investigational New Drug (IND) Application for MesenCure™ Phase III Clinical Study in Respiratory Distress.SourceShare this post
![[Infographic] Môi trường nuôi cấy thế hệ thứ 3: CD AOF (Chemically Defined & Animal Origin Free)](https://biogroupvietnam.com/wp-content/uploads/2026/02/infographic-moi-truong-nuoi-cay-the-he-thu-3-cd-aof-200x150.png)
